AzTrials
AzTrials

Weight LossHelplineNCT06463249

Behavioral Weight Loss for Cancer Survivors in Maryland: A Trial With Adaptive Interventions

A study testing CORE Helpline, Extended Helpline and Enhanced Helpline in people with Weight Loss, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The objective of the HELPLINE Weight Loss Program is to determine the comparative effectiveness of two active multi-component, augmented interventions for cancer survivors with overweight or obesity who do not achieve early weight loss goal in the initial intervention period (termed, early non-responders). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Weight Loss
What is being tested?
CORE Helpline, Extended Helpline and Enhanced Helpline
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteUnited States
Study dates
17 Jun 2024to Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Women and men ages 18 or older
  • Able to complete all study requirements in English
  • Have been previously diagnosed with a malignant solid tumor, completed the required surgical, and/or chemotherapy and/or radiation curative intent therapy at least three months prior to enrollment, and have an anticipated treatment-free life span of 12 months or longer. Chemoprophylaxis with tamoxifen or aromatase inhibitors for breast cancer in women and anti- luteinizing hormone-releasing hormone (LHRH) therapy for prostate cancer in men will be permitted.
  • Have a BMI ≥ 27 kg/m2 (BMI ≥ 25 kg/m2 for Asians) and weight ≤ 400 lbs.
  • Have an email address for regular personal use
  • Have a smartphone for personal use, and are willing to use the phone to read emails and text messages, and use an app
Show all 11Show fewer
  • Have adequate data plan and cell service to support daily use of weight loss app, receive text messages and to support coaching calls
  • Are willing to record weekly weights
  • Are willing to use a tracking app to log food and exercise daily
  • Are willing to complete coaching calls as planned
  • Are willing to prioritize weight loss efforts by making dietary changes and increasing physical activity

Who cannot join

  • Received any chemotherapy (unless anti-hormonal therapy) and/or radiation three months or less prior to the proposed program date
  • Women who are breastfeeding, pregnant, or planning pregnancy within the next year
  • self-identification of uncontrolled concurrent medical condition likely to limit compliance with the program as determined by investigators.
  • current involvement in another organized weight loss program
  • current use of medications known to substantially affect body weight, including chronic oral steroids, Tirzepatide (Mounjaro™), and weight loss doses of other glucagon-like peptide 1 (GLP-1) agonists (e.g. Wegovy.)
  • bariatric surgery scheduled within the next 12 months
  • plan to move outside the continental United States in the next 12 months
  • Weight loss or gain of >5.0% of body weight during 2 months prior to screening

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Johns Hopkins ProHealth

    Baltimore, Maryland, 21207

Other trials in United States

About this study

Official title: Scaling up Behavioral Weight Loss Opportunities for Cancer Survivors With Overweight or Obesity in Maryland: A Randomized Trial With Adaptive Interventions (Helpline for Weight Loss)

The objective of the HELPLINE Weight Loss Program is to determine the comparative effectiveness of two active multi-component, augmented interventions for cancer survivors with overweight or obesity who do not achieve early weight loss goal in the initial intervention period (termed, early non-responders). The core study design is randomized controlled trial with adaptive intervention.

  1. CORE Helpline in all participants (first 2 months)
  2. Extended Helpline in early responders (additional 6 months)
  3. Enhanced Helpline in early non-responders (additional 6 months)
  4. Intensive Helpline in early non-responders (additional 6 months)
Read the detailed description

All participants will receive

  • written Johns Hopkins weight loss material
  • instructions for using a smartphone weight loss app to keep track of food and exercise every day (either android or iPhone)
  • a weekly weight loss tip by text message and email, and a text message on weight loss progress each week
  • a research scale and specific instructions for verifying weights at 5 specific times over the next year.

The participants may also request two 20-minute phone calls during the first 2 months with a weight loss coach.

After the first 2 months, depending on weight loss progress, the participants will be assigned to another program which may include additional assistance for 6 more months.

Additional assistance may include scheduled phone calls with a Johns Hopkins weight loss coach each month, individualized emails from a Johns Hopkins weight loss coach, and the option for daily text message reminders.

After the first 8 months of assistance, the participants will continue the program on the participant's own for 4 more months and provide the study team with final weights 12 months after the start of the program.

Conditions
Weight Loss
Being tested
CORE Helpline, Extended Helpline, Enhanced Helpline, Intensive Helpline
Medical subject headings
Weight Loss

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CORE HelplineBehavioural

    All participants will receive the Core Helpline program (CORE) for 2 months, which includes written weight loss material, use of a smartphone app, weekly text messages and email reminders and 1 optional participant-initiated coaching call per month.

  • Extended HelplineBehavioural

    Those who achieved 2% weight loss at 2-month, will continue to Extended Helpline, where the participants can continue receiving all CORE resources including1-on-1 coaching through 1 optional participant-initiated call per month for 6 months.

  • Enhanced HelplineBehavioural

    Those who do not reach 2% weight loss at the end of 2 months will be randomized. Participants will continue to receive all CORE resources plus 1 optional participant-initiated call/month for 6 months. Additionally, the participants will receive 2 individualized coach-scripted feedback emails per month, and the option to receive daily text message reminders.

  • Intensive HelplineBehavioural

    Those who do not reach 2% weight loss at the end of 2 months will be randomized. Participants will continue to receive all CORE resources plus 2 scheduled coaching calls/month for 6 months. Additionally, the participants will receive 2 individual coach-scripted feedback emails per month, and the option to receive daily text message reminders.

Study groups in NCT06463249
Study groupRoleWhat they receive
Intensive HelplineExperimentalParticipants receive 2 scheduled coaching calls/month and individualized coach-scripted feedback via emails twice/month for 6 months.
Receives: Behavioral: CORE Helpline; Behavioral: Intensive Helpline
Enhanced HelplineActive comparatorParticipants receive 1 participant-initiated call/month. Additionally, the participants receive individualized coach-scripted feedback via emails twice/month for 6 months
Receives: Behavioral: CORE Helpline; Behavioral: Enhanced Helpline
Extended HelplineOtherParticipants who achieved 2% weight loss at 2-month, will continue to Extended Helpline, where the participants can continue receiving 1-on-1 coaching through 1 participant-initiated calls per month for 6 months.
Receives: Behavioral: CORE Helpline; Behavioral: Extended Helpline
CORE HelplineOtherAll participants will receive the CORE Helpline program for 2 months
Receives: Behavioral: CORE Helpline

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Weight (pounds) changes at 8 months from 2-month between Enhanced Helpline and Intensive Helpline arms

    Weight change for Enhanced Helpline and Intensive Helpline in early non-responders

    Measured: 8 months

Secondary outcomes (1)
  1. Weight (pounds) change at 5 and 12 months from 2-month between Enhanced Helpline and Intensive Helpline arms

    Weight change for Enhanced Helpline and Intensive Helpline in early non-responders

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jun 2024
  2. Study start17 Jun 2024
  3. Primary completionJul 2027 (estimated)
  4. Study completionDec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Sequential
Model description
All participants will receive Core Helpline intervention in the first two months. If participants achieve 2% or more weight loss in two months (i.e. early responders), they will continue to the Extended Helpline. If participants do not achieve at least 2% of weight loss in two months (i.e. early non-responders), they will be randomized to one of two stepped-up interventions: Enhanced Helpline or Intensive Helpline.
Masking
None (open label)
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06463249
Sponsor's protocol ID
IRB00403808
Acronym
Helpline
Status last verified
Jul 2026
First submitted
12 Jun 2024
Last updated
20 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing CORE Helpline, Extended Helpline and Enhanced Helpline in people with Weight Loss, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 20 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Weight (pounds) changes at 8 months from 2-month between Enhanced Helpline and Intensive Helpline arms (time frame: 8 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in